Hinge Health, Inc. (NYSE:HNGE) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Hinge Health, Inc. ...

Investing.com -- Stifel on Tuesday initiated coverage of MHA plc with a “buy” rating and a target price of 205p, representing 35% potential upside from the stock’s closing price of 151.5p on Feb. 16.

We recently published an article titled 10 Best Low Volatility Canadian Stocks to Buy. On February 10, Stifel raised its ...

Investing.com -- Stifel reiterated its Buy rating on Rivian and raised its price target to $20 from $17 after fourth-quarter results and 2026 guidance topped its expectations. The firm said the ...

"From a corporate sponsorship point, we want to own the sport. Well, that has helped the athletes and they will say that," Stifel CEO Ron Kruszewski said.

When structured notes or products go wrong, broker-dealers can wind up in costly litigation. A three-person FINRA arbitration ...

Evidence of durability of psilocybin-based COMP360 is a key point for the FDA, according to Compass Pathways Chief Medical ...

Olema Pharmaceuticals (NASDAQ:OLMA) is one of the 17 biotechnology stocks with more than 50% upside. On February 11, Laura Prendergast of Stifel Nicolaus initiated coverage of Olema Pharmaceuticals ...

Fintel reports that on February 11, 2026, Stifel initiated coverage of BridgeBio Oncology Therapeutics (NasdaqGM:BBOT) with a Buy recommendation. Analyst Price Forecast Suggests 118.90% Upside As of ...

Q4 2025 earnings call recap: sales, EBITDA and record free cash flow, plus 2026 outlook on cost cuts, pricing, AI and debt.

Candel Therapeutics Inc (NASDAQ:CADL) on Thursday announced two financing initiatives to support the potential US launch of its cancer therapy aglatimagene besadenovec (CAN-2409) for intermediate- to ...

The agreement, announced after the market closed on Tuesday, pushed Nvidia shares up 2.3% to $191.40 on Wednesday. The ...